The concern is grounded in a specific physiological reality: up to 40% of total weight lost on high-efficacy GLP-1 medications is lean body mass, not fat, according to body composition studies cited in recent Harvard Science Review analysis and a Nature Reviews Endocrinology correspondence published in 2026
Glutathione, as a natural antioxidant, helps to combat these symptoms and restore bone mass
How is retatrutide different from semaglutide or tirzepatide
Over the last 5 years, with the emergence of newer agents including sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 RA) and novel mineralocorticoid receptor antagonist (MRA), management of type 2 diabetes mellitus (T2DM) and DKD has since shifted away from a glucose-centric focus towards one of heart and kidney protection [35]
7.3 From PCOS to endotypes: the role of ML in stratification over promises The diagnostic label of PCOS encompasses a highly heterogeneous pathophysiological spectrum
The good news is that GLP-1 related hair loss is almost always temporary, driven by well-understood biological mechanisms, and highly responsive to prevention strategies when you know what to do
